Company intelligence

Debios Diagnostics

Redefining kidney care with non-invasive fibrosis diagnostics

Biotechnology Research
Badalona, ES
2–10 employees
Founded 2023
3 public signals

About Debios Diagnostics

Debios is a spin-off from the Barcelona-based hospital research institute IGTP, developing non-invasive diagnostic solutions to improve kidney health. Its lead product, FIBROKIT®, is a urine-based test for the assessment of renal fibrosis, designed to support earlier clinical action and monitoring in chronic kidney disease and kidney transplantation.

Verified activity

Signals from Debios Diagnostics

3 published signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.